Merck KGaA’s U.S. research site has newly affirmed an in-office work requirement that may lead to the imminent departure of as many as 70 staffers. Merck’s North American division, EMD Serono, “has ...
Remote work is coming to an end for 70 employees with EMD Serono Research & Development Institute Inc., a pharmaceutical ...
A month after Genentech confirmed the restructuring of its early development group, the Roche subsidiary has now disclosed ...
Two New Jersey employers are planning 260 job cuts by late summer to early fall, according to notices filed Monday. The filings add to a growing number of workforce reductions across the state this ...
AT&T will lay off 138 employees at its Cumberland County office after Labor Day weekend, according to a Worker Adjustment and Retraining Notification filed Thursday. The job cuts are scheduled to take ...
Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota history. The sale follows investor pressure on Minneapolis-based Bio-Techne, ...
Travel + Leisure Co. , a leading leisure travel company, today announced the closing of the acquisition of Yes& Vacations and, separately, entering into a definitive agreement to acquire Spinnaker ...
Latham & Watkins LLP1 is pleased to announce that prominent capital markets partner Byron Rooney will be joining the firm along with partner Dan Gibbons who has joined. Nationally recognized leader ...
Sydney and Kuala Lumpur events unite world-leading experts as Mitochondrial Health gains recognition as a defining force in healthy ageing, and healthspan Researchers and clinicians identify Ubiquinol ...
Officials set on fire more than 50 tons of illegal drugs, including heroin, opium, ketamine, methamphetamine, marijuana, and ...
German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.
The chair of the U.S. House Select Committee on China opened national security investigations into whether five drugmakers including Merck and AbbVie have been involved in clinical trials conducted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results